Protist Metabolome Screening (PROMISE) | Marinebiotech

www.marinebiotech.eu/PROMISE

Protist Metabolome Screening (PROMISE)

Abstract

Marine eukaryotic protists offer a huge but currently underexploited reservoir of metabolic pathways with biotechnological potential. Given their unique adaptations through symbiosis, endosymbiosis and organelle acquisition, the ecofunctionalities of protists present a hitherto untapped source to discover novel metabolic pathways and bioactivities whilst bearing a high chance of discovering different activities compared to those identified in marine sources, such as bacteria.

The scientific approach and rationale sets PROMiSE apart from many previous scientific initiatives exploiting the biotechnological potential of marine bacteria. The PROMiSE experimental workflow enables this by employing a comprehensive set of Omics methods. This approach spans the encoded metabolic potential to identify biosynthetic gene clusters which in turn guide the targeted metabolite profiling, merged with discovery-based metabolomics. The goal is to target identified candidate compound classes and their pathway-related metabolites and conjugations dereplicated from the Omics information. By linking these methods back to the source cell through single cell Omics methods, PROMiSE offers a unique way to recognize functional gene clusters and to understand how metabolism is partitioned across ecosystems. This is important to unravel how the identified pathways work in nature, and by extension, how they can be expressed and utilized for technological adaptations relevant to a human health and biotechnology market.

The vertically integrated extraction and analyses procedure within PROMiSE are supported by a comprehensive array of cutting-edge in vitro and in vivo bioassays for reliably assessing biological activities by High-Content profiling and antibacterial screening. Analytical chemistry, including high resolution mass spectroscopy and nuclear magnetic resonance spectroscopy approaches, will be used to elucidate compounds found in the bioactive fractions, which will tie back the molecular data to identify relevant enzymes, pathways, and compounds.

Coordinator

Tilmann Harder, Alfred Wegener Institut, Helmholtz Zentrum für Polar und Meeresforschung, Germany

Consortium

Name

Organisation

Country

Tilmann Harder

Alfred Wegener Institut, Helmholtz Zentrum für Polar und Meeresforschung

Germany

Ramon Massana

Institut de Ciències del Mar (CSIC)

Spain

Patrick Keeling

University of British Columbia

Canada

Phillipe Schmitt-Kopplin

Helmholtz Zentrum München

Germany

Bente Edvardsen

University of Oslo (UiO)

Norway

Factsheet

Download here